For the Inventor, By the Inventor

Enter assignee name

Taigen Biotechnology Company, Ltd.

USPTO Granted Patents = 16

CIPO Patents = 4

EPO Patents = 6

Forward Citations = 29

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Chi-Feng Yen (9 out of 12 patents)

Chi-Hsin Richard King (9 out of 10 patents)

Ming-Chu Hsu (6 out of 11 patents)

4. Chu-Chung Lin (5 out of 12 patents)

5. Ying-Huey Huang (4 out of 6 patents)

6. Shu-Jen Chen (4 out of 12 patents)

7. Wen-Chang Chen (3 out of 18 patents)

8. Shan-Yen Chou (2 out of 7 patents)

9. Han-Pei Hsu (2 out of 2 patents)

10. Yibin Xiang (2 out of 21 patents)

11. Cheng-Kung Hu (2 out of 3 patents)

12. Gholam Hossein Hakimelahi (2 out of 4 patents)

13. Chien-Huang Wu (2 out of 9 patents)

14. Pei-Chin Cheng (2 out of 3 patents)

15. Michael Reilly (1 out of 11 patents)

16 patents: Sort by Forward Citations

1. 11872224 - Amorphous solid dispersion formulation (2024-01-16),

2. 11639349 - Stereoselective synthesis of intermediate for preparation of heterocyclic compound (2023-05-02),

3. 10596171 - Cap-dependent endonuclease inhibitors (2020-03-24),

4. 10377714 - Trans-isomeric heterocyclic compounds and preparation thereof (2019-08-13),

5. 10004719 - Solid dispersion formulation (2018-06-26),

6. 9375406 - Substituted pyrimidines for mobilizing cells expressing a type 4 CXC chemokine receptor (2016-06-28),

7. 9023834 - Lyophilization formulation (2015-05-05),

8. 8658183 - Antimicrobial parenteral formulation (2014-02-25),

9. 8389560 - HCV protease inhibitors (2013-03-05),

10. 8372849 - Heterocyclic compounds (2013-02-12),

11. 8211909 - Treatment of antibiotic-resistant bacteria infection (2012-07-03),

12. 8193206 - Pyrimidine compounds (2012-06-05),

13. 8158798 - Coupling process for preparing quinolone intermediates (2012-04-17),

14. 7504422 - Polyamine compounds (2009-03-17),

15. 7462594 - Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases (2008-12-09),

Taigen Biotechnology Company, Ltd. is a leading biotechnology company that specializes in developing innovative solutions for the healthcare industry. We are dedicated to advancing medical research and improving patient outcomes through the development of cutting-edge biopharmaceuticals and diagnostic tools. Our team of experienced scientists and researchers work diligently to discover and develop novel therapeutics that target a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. At Taigen Biotechnology, we strive to make a positive impact on global health by providing safe and effective treatment options. Learn more about our groundbreaking work on our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#329 in Taipei

#956 in Taiwan

#36,671 in the World

Taigen Biotechnology Company, Ltd.

Forward Citations = 29

43 inventors:

Chi-Feng Yen (9 out of 12 patents)

Chi-Hsin Richard King (9 out of 10 patents)

Ming-Chu Hsu (6 out of 11 patents)

4. Chu-Chung Lin (5 out of 12 patents)

5. Ying-Huey Huang (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…